Filters
reset allTests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Elevated Levels of C5-hydroxyacylcarnitine (C5-OH) Panel PreventionGenetics, part of Exact Sciences United States | 7 | 7 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
PreventionGenetics, part of Exact Sciences United States | 66 | 63 |
|
Lysosomal Storage Disorders Panel PreventionGenetics, part of Exact Sciences United States | 242 | 146 |
|
BTD Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 1 | 1 |
|
Baylor Genetics United States | 1 | 1 |
|
Biotinidase Deficiency via the BTD Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Integrated Genetics Westborough LabCorp United States | 330 | 746 |
|
Targeted Variant, Fetal Analysis Integrated Genetics Westborough LabCorp United States | 292 | 746 |
|
HNL Genomics Connective Tissue Gene Tests United States | 44 | 45 |
|
NxGen MDx United States | 116 | 117 |
|
NxGen MDx United States | 113 | 115 |
|
Natera, Inc. United States | 265 | 275 |
|
Natera, Inc. United States | 265 | 274 |
|
Natera, Inc. United States | 135 | 138 |
|
Natera, Inc. United States | 135 | 137 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.